Incyte (INCY) Target Price Lifted at BofA/Merrill Lynch Following Following Physician Jakafri Survey
Tweet Send to a Friend
BofA/Merrill Lynch analyst Steve Byrne reiterated a Buy rating and boosted his price target on Incyte (NASDAQ: INCY) to $92.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
